These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20374155)

  • 1. Lithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patients.
    Silverstone PH; McGrath BM
    Int Rev Psychiatry; 2009; 21(4):414-23. PubMed ID: 20374155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
    Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
    Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings.
    Silverstone PH; McGrath BM; Kim H
    Bipolar Disord; 2005 Feb; 7(1):1-10. PubMed ID: 15654927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.
    Forester BP; Finn CT; Berlow YA; Wardrop M; Renshaw PF; Moore CM
    Bipolar Disord; 2008 Sep; 10(6):691-700. PubMed ID: 18837863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients.
    Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
    Int Clin Psychopharmacol; 2003 Mar; 18(2):73-9. PubMed ID: 12598817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol.
    McGrath BM; Greenshaw AJ; McKay R; Slupsky CM; Silverstone PH
    Neuroreport; 2007 Oct; 18(15):1595-8. PubMed ID: 17885608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The place of anticonvulsants and other putative mood stabilisers in the treatment of bipolar disorder.
    Mitchell PB
    Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S99-107. PubMed ID: 10622184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mood stabilizers: protecting the mood...protecting the brain.
    Brunello N
    J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies.
    Kim H; McGrath BM; Silverstone PH
    Hum Psychopharmacol; 2005 Jul; 20(5):309-26. PubMed ID: 15880397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.
    O'Donnell T; Rotzinger S; Nakashima TT; Hanstock CC; Ulrich M; Silverstone PH
    Brain Res; 2000 Oct; 880(1-2):84-91. PubMed ID: 11032992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate and neuroprotective effects for bipolar disorder.
    Atmaca M
    Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Older patients are eligible for trial of lithium and valproate.
    Rendell JM; Geddes JR; Ostacher MJ
    BMJ; 2003 Aug; 327(7411):395-6. PubMed ID: 12920009
    [No Abstract]   [Full Text] [Related]  

  • 13. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex.
    Moore CM; Breeze JL; Gruber SA; Babb SM; Frederick BB; Villafuerte RA; Stoll AL; Hennen J; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Bipolar Disord; 2000 Sep; 2(3 Pt 2):207-16. PubMed ID: 11249799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast bioassay for identification of inositol depleting compounds.
    Ding D; Shi Y; Shaltiel G; Azab AN; Pullumbi E; Campbell A; Mehta DV; Agam G; Greenberg ML
    World J Biol Psychiatry; 2009; 10(4 Pt 3):893-9. PubMed ID: 18979283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between lithium and valproate in the treatment of acute mania.
    Shafti SS; Shahveisi B
    J Clin Psychopharmacol; 2008 Dec; 28(6):718-20. PubMed ID: 19011453
    [No Abstract]   [Full Text] [Related]  

  • 16. Sodium-myo-inositol co-transporter (SMIT-1) mRNA is increased in neutrophils of patients with bipolar 1 disorder and down-regulated under treatment with mood stabilizers.
    Willmroth F; Drieling T; Lamla U; Marcushen M; Wark HJ; van Calker D
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):63-71. PubMed ID: 16420717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited.
    Harwood AJ
    Mol Psychiatry; 2005 Jan; 10(1):117-26. PubMed ID: 15558078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical neurochemistry in euthymic patients with bipolar I disorder.
    Scherk H; Backens M; Schneider-Axmann T; Usher J; Kemmer C; Reith W; Falkai P; Gruber O
    World J Biol Psychiatry; 2009; 10(4):285-94. PubMed ID: 19921970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.